445 related articles for article (PubMed ID: 24333267)
1. The association of FOXO3A gene polymorphisms with serum FOXO3A levels and oxidative stress markers in vitiligo patients.
Ozel Turkcu U; Solak Tekin N; Gokdogan Edgunlu T; Karakas Celik S; Oner S
Gene; 2014 Feb; 536(1):129-34. PubMed ID: 24333267
[TBL] [Abstract][Full Text] [Related]
2. Involvement of superoxide dismutase isoenzymes and their genetic variants in progression of and higher susceptibility to vitiligo.
Laddha NC; Dwivedi M; Gani AR; Shajil EM; Begum R
Free Radic Biol Med; 2013 Dec; 65():1110-1125. PubMed ID: 24036105
[TBL] [Abstract][Full Text] [Related]
3. Analysis of oxidative stress status, catalase and catechol-O-methyltransferase polymorphisms in Egyptian vitiligo patients.
Mehaney DA; Darwish HA; Hegazy RA; Nooh MM; Tawdy AM; Gawdat HI; El-Sawalhi MM
PLoS One; 2014; 9(6):e99286. PubMed ID: 24915010
[TBL] [Abstract][Full Text] [Related]
4. Analysis of allelic variants in the catalase gene in patients with the skin depigmenting disorder vitiligo.
Gavalas NG; Akhtar S; Gawkrodger DJ; Watson PF; Weetman AP; Kemp EH
Biochem Biophys Res Commun; 2006 Jul; 345(4):1586-91. PubMed ID: 16729966
[TBL] [Abstract][Full Text] [Related]
5. The catalase gene promoter and 5'-untranslated region variants lead to altered gene expression and enzyme activity in vitiligo.
Mansuri MS; Jadeja SD; Singh M; Laddha NC; Dwivedi M; Begum R
Br J Dermatol; 2017 Dec; 177(6):1590-1600. PubMed ID: 28542879
[TBL] [Abstract][Full Text] [Related]
6. SIRT1 signalling protects mouse oocytes against oxidative stress and is deregulated during aging.
Di Emidio G; Falone S; Vitti M; D'Alessandro AM; Vento M; Di Pietro C; Amicarelli F; Tatone C
Hum Reprod; 2014 Sep; 29(9):2006-17. PubMed ID: 24963165
[TBL] [Abstract][Full Text] [Related]
7. Association of the Ala16Val MnSOD gene polymorphism with plasma leptin levels and oxidative stress biomarkers in obese patients.
Becer E; Çırakoğlu A
Gene; 2015 Aug; 568(1):35-9. PubMed ID: 25958349
[TBL] [Abstract][Full Text] [Related]
8. TLR2 and TLR4 gene polymorphisms in Turkish vitiligo patients.
Karaca N; Ozturk G; Gerceker BT; Turkmen M; Berdeli A
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e85-90. PubMed ID: 22429552
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation and human longevity.
Soerensen M
Dan Med J; 2012 May; 59(5):B4454. PubMed ID: 22549493
[TBL] [Abstract][Full Text] [Related]
10. Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous skin.
Sravani PV; Babu NK; Gopal KV; Rao GR; Rao AR; Moorthy B; Rao TR
Indian J Dermatol Venereol Leprol; 2009; 75(3):268-71. PubMed ID: 19439879
[TBL] [Abstract][Full Text] [Related]
11. No association between catalase (CAT) gene polymorphisms and susceptibility to vitiligo in a Turkish population.
Akbas H; Dertlioglu SB; Dilmec F; Balkan M
Clin Ter; 2013; 164(3):e173-7. PubMed ID: 23868633
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-4 genetic variants correlate with its transcript and protein levels in patients with vitiligo.
Imran M; Laddha NC; Dwivedi M; Mansuri MS; Singh J; Rani R; Gokhale RS; Sharma VK; Marfatia YS; Begum R
Br J Dermatol; 2012 Aug; 167(2):314-23. PubMed ID: 22512783
[TBL] [Abstract][Full Text] [Related]
13. Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population.
Dwivedi M; Laddha NC; Mansuri MS; Marfatia YS; Begum R
Br J Dermatol; 2013 Nov; 169(5):1114-25. PubMed ID: 23773036
[TBL] [Abstract][Full Text] [Related]
14. Analysis of myeloperoxidase promotor polymorphism and enzyme activity in Turkish patients with vitiligo.
Aksoy SN; Erbagci Z; Saygili EI; Sever T; Erbagci AB; Pehlivan S
Eur J Dermatol; 2009; 19(6):576-80. PubMed ID: 19758957
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress in the blood of patients with active localized vitiligo.
Arican O; Kurutas EB
Acta Dermatovenerol Alp Pannonica Adriat; 2008 Mar; 17(1):12-6. PubMed ID: 18454264
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of manganese superoxide dismutase by angiotensin II in cardiac fibroblasts of rats: Association with oxidative stress in myocardium.
Lijnen PJ; van Pelt JF; Fagard RH
Am J Hypertens; 2010 Oct; 23(10):1128-35. PubMed ID: 20596034
[TBL] [Abstract][Full Text] [Related]
17. Association study between catalase gene polymorphisms and the susceptibility to vitiligo in Korean population.
Park HH; Ha E; Uhm YK; Jin SY; Kim YJ; Chung JH; Lee MH
Exp Dermatol; 2006 May; 15(5):377-80. PubMed ID: 16630078
[TBL] [Abstract][Full Text] [Related]
18. Association of FOXP3 (rs3761548) promoter polymorphism with nondermatomal vitiligo: A study from India.
Jahan P; Cheruvu R; Tippisetty S; Komaravalli PL; Valluri V; Ishaq M
J Am Acad Dermatol; 2013 Aug; 69(2):262-6. PubMed ID: 23498308
[TBL] [Abstract][Full Text] [Related]
19. SIRT1 Protects Against Oxidative Stress-Induced Endothelial Progenitor Cells Apoptosis by Inhibiting FOXO3a via FOXO3a Ubiquitination and Degradation.
Wang YQ; Cao Q; Wang F; Huang LY; Sang TT; Liu F; Chen SY
J Cell Physiol; 2015 Sep; 230(9):2098-107. PubMed ID: 25640014
[TBL] [Abstract][Full Text] [Related]
20. Catalase but not vitamin D receptor gene polymorphisms are associated with nonsegmental vitiligo in Northwestern Mexicans.
Ochoa-Ramírez LA; Díaz-Camacho SP; Becerra-Loaiza DS; Verdugo-Nieto L; Muñoz-Estrada VF; Servín-Vázquez LA; Osuna-Ramírez I; Rodríguez-Millán J; Velarde-Félix JS
Int J Dermatol; 2019 Nov; 58(11):1264-1269. PubMed ID: 31120146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
